We previously showed the mRNA expression of all five SSTR subtypes in glioma and meningioma samples using Northern blot analysis and RT-PCR techniques and described that SSTR2 mRNA was the most abundantly expressed in both meningiomas and glioma samples [123]. This evidence concerns the gene SSTR2 and central nervous system cancer.